Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × belzutifan × Clear all

Phase

Status

Recruiting 4 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 851 Radiotherapy 763 Cisplatin 657 Gemcitabine 583 Docetaxel 538 Carboplatin 538 Paclitaxel 529 Bevacizumab 513 Fluorouracil 452 Rituximab 412 Oxaliplatin 405 Capecitabine 400 Surveys and Questionnaires 391 Dexamethasone 388 Doxorubicin 381 Etoposide 367 Irinotecan 351 Cytarabine 333 Filgrastim 330 pembrolizumab 277 Leucovorin 277 Melphalan 266 fludarabine phosphate 261 Magnetic Resonance Spectroscopy 259 Nivolumab 254 Blood Specimen Collection 251 Lenalidomide 244 Peripheral Blood Stem Cell Transplantation 242 Methotrexate 239 Cetuximab 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04627064 2025-07-25

ABEMA Alone or in COMBO With MK-6482

Dana-Farber Cancer Institute

Phase 1 Completed

11 enrolled 9 charts

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡